Health Market Science

Health Market Science will be exhibiting and speaking at CBI's 9th Annual Pharmaceutical Compliance Congress.

The expectations of what constitutes an effective compliance program continue to evolve each year.  Repeated high-dollar settlements and high-profile CIAs exemplify the need for innovative compliance solutions.  The demand for well-trained, thoughtful and decisive compliance professionals is at an all-time high.

CBI’s Compliance Series addresses all aspects of a corporate compliance program to bring together Chief Compliance Officers and their teams to share best practices and evolve compliance efforts across the industry.  This Series is headlined by this flagship meeting, CBI’s Annual Pharmaceutical Compliance Congress. 

Chief Compliance Officers and their industry compliance, legal and regulatory peers create an expert speaking faculty ready to engage the audience in interactive and insightful programming.

Addresses from the Presidents of large and small pharmaceutical companies and critical perspectives from a variety of government speakers representing FDA, DOJ’s Main Justice, the SEC and state U.S. Attorney’s Offices and Attorneys General Offices are always highlights of the meeting.

The interactive format of the Congress affords attendees the opportunity to choose their own conference agenda and interact directly with their peers in focused settings.  A variety of interactive break-out sessions are designed for the novice, the advanced or for those with a specific responsibility within the compliance department such as monitoring.  Full-day tracked programming addresses Fraud and Abuse, Global Compliance, Product Promotional Compliance and Aggregate Spend. The Chief Compliance Officers participate in an exclusive closed-door summit.

Location